Literature DB >> 17764158

An intermediate structure in the thermal unfolding of the GTPase domain of human septin 4 (SEPT4/Bradeion-beta) forms amyloid-like filaments in vitro.

Wanius Garcia1, Ana Paula Ulian de Araújo, Flavio Lara, Debora Foguel, Manami Tanaka, Tomoo Tanaka, Richard Charles Garratt.   

Abstract

SEPT4 is a member of the mammalian septin family of GTPases. Mammalian septins are conserved proteins which form heteropolymers in vivo and which are implicated in a variety of cellular functions such as cytokinesis, exocytosis, and vesicle trafficking. However, their structural properties and modes of action are largely unknown. There is a limited, but as yet inconclusive, amount of experimental data suggesting that SEPT4 may accumulate in tau-based filamentous deposits and cytoplasmic inclusions in Alzheimer's and Parkinson's disease, respectively. Here we report an intermediate structure of the GTPase domain of human SEPT4 (SEPT4-G) during unfolding transitions induced by temperature. This partially unfolded intermediate, which is rich in beta-sheet and free of bound nucleotide, was plagued by irreversible aggregation. The aggregates have the ability to bind specific dyes such as Congo red and thioflavin-T, suggesting they are amyloid in nature. Under electron microscopy, fibers of variable diameter extending for several micrometers in length can be visualized. This is the first report of amyloid formation by a septin or domain thereof, and the capacity of SEPT4-G to form such fibrillar aggregates may shed some light on the current discussion concerning the formation of homo- and heteropolymers of septins in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764158     DOI: 10.1021/bi700702w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  SEPT4 is regulated by the Notch signaling pathway.

Authors:  Wenbin Liu
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  Turning it inside out: The organization of human septin heterooligomers.

Authors:  Michael A McMurray; Jeremy Thorner
Journal:  Cytoskeleton (Hoboken)       Date:  2019-10-29

Review 3.  Defining the limits: Protein aggregation and toxicity in vivo.

Authors:  William M Holmes; Courtney L Klaips; Tricia R Serio
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-04-28       Impact factor: 8.250

4.  Uncovering principles that control septin-septin interactions.

Authors:  Moshe S Kim; Carol D Froese; Hong Xie; William S Trimble
Journal:  J Biol Chem       Date:  2012-07-18       Impact factor: 5.157

5.  Cloning, overexpression, purification and preliminary characterization of human septin 8.

Authors:  T A C B Souza; J A R G Barbosa
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

6.  Effect of pH and temperature on the global compactness, structure, and activity of cellobiohydrolase Cel7A from Trichoderma harzianum.

Authors:  Francieli Colussi; Wanius Garcia; Flávio Rodolfo Rosseto; Bruno Luan Soares de Mello; Mário de Oliveira Neto; Igor Polikarpov
Journal:  Eur Biophys J       Date:  2011-11-03       Impact factor: 1.733

7.  Structural and Thermodynamic Properties of Septin 3 Investigated by Small-Angle X-Ray Scattering.

Authors:  Maria Grazia Ortore; Joci N A Macedo; Ana Paula U Araujo; Claudio Ferrero; Paolo Mariani; Francesco Spinozzi; Rosangela Itri
Journal:  Biophys J       Date:  2015-06-16       Impact factor: 4.033

Review 8.  Septin structure and filament assembly.

Authors:  Napoleão Fonseca Valadares; Humberto d' Muniz Pereira; Ana Paula Ulian Araujo; Richard Charles Garratt
Journal:  Biophys Rev       Date:  2017-09-13

Review 9.  [Functional Characterization of Septin Complexes].

Authors:  K A Akhmetova; I N Chesnokov; S A Fedorova
Journal:  Mol Biol (Mosk)       Date:  2018 Mar-Apr

10.  Cytosolic chaperones mediate quality control of higher-order septin assembly in budding yeast.

Authors:  Courtney R Johnson; Andrew D Weems; Jennifer M Brewer; Jeremy Thorner; Michael A McMurray
Journal:  Mol Biol Cell       Date:  2015-02-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.